CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 09/30/2014

Position Statistics

Total Positions 68
New Positions 16
Increased Positions 24
Decreased Positions 13
Positions with Activity 37
Sold Out Positions 4
Total Mkt Value (in $ millions) 621

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 14.81%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 62.43%
Services
Technology
Transportation
Utilities

68 Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
ACADIA PHARMACEUTICALS COM -1,594 Sold Out 0
CELGENE CORP COM -24,778 Sold Out 0
MALLINCKRODT PUB LTD CO SHS -28,820 Sold Out 0
MERCK & CO INC NEW COM -6,249 Sold Out 0
CELLECTAR BIOSCIENCES INC WT EXP 081919 302 302 New 530,000
SAGE THERAPEUTICS INC COM 383 383 New 10,000
MINERVA NEUROSCIENCES INC COM 901 901 New 175,000
CURIS INC COM 1,002 New 600,000
AGILE THERAPEUTICS INC COM 1,131 New 150,000
SCYNEXIS INC COM 1,199 New 100,000
CELLECTAR BIOSCIENCES INC COM NEW 1,330 1,330 New 530,000
CELSUS THERAPEUTICS PLC SPONSORED ADR NE 1,377 797 137.38 244,500
APPLIED GENETIC TECHNOL CORP COM 1,456 -3,795 (72.28) 60,600
GALECTIN THERAPEUTICS INC COM NEW 1,536 -1,192 (43.7) 450,400
RECRO PHARMA INC COM 2,212 632 40 700,000
ZS PHARMA INC COM 2,300 2,300 New 50,000
KINDRED BIOSCIENCES INC COM 2,433 1,738 250 350,000
AVALANCHE BIOTECHNOLOGIES INC COM 2,595 2,595 New 65,000
ADVAXIS INC COM NEW 2,706 2,706 New 350,000
AQUINOX PHARMACEUTICALS INC COM 3,018 New 300,000